1. Home
  2. TENX vs FLYE Comparison

TENX vs FLYE Comparison

Compare TENX & FLYE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Tenax Therapeutics Inc.

TENX

Tenax Therapeutics Inc.

N/A

Current Price

$1.93

Market Cap

74.1M

Sector

Health Care

ML Signal

N/A

Logo Fly-E Group Inc.

FLYE

Fly-E Group Inc.

N/A

Current Price

$1.33

Market Cap

2.3M

Sector

Industrials

ML Signal

N/A

Company Overview

Basic Information
Metric
TENX
FLYE
Founded
1967
2018
Country
United States
United States
Employees
16
12
Industry
Biotechnology: Pharmaceutical Preparations
Aerospace
Sector
Health Care
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
74.1M
2.3M
IPO Year
2001
2024

Fundamental Metrics

Financial Performance
Metric
TENX
FLYE
Price
$1.93
$1.33
Analyst Decision
Buy
Analyst Count
10
0
Target Price
★ $12.56
N/A
AVG Volume (30 Days)
★ 3.0M
207.4K
Earning Date
11-11-2026
09-01-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ 61.82
EPS
★ N/A
N/A
Revenue
N/A
★ $19,063,357.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
★ N/A
N/A
Revenue Growth
N/A
★ N/A
52 Week Low
$1.31
$0.48
52 Week High
$19.40
$21.80

Technical Indicators

Market Signals
Indicator
TENX
FLYE
Relative Strength Index (RSI) 29.79 39.47
Support Level $1.31 $1.32
Resistance Level $2.22 $1.92
Average True Range (ATR) 0.09 0.20
MACD 0.26 -0.03
Stochastic Oscillator 58.88 12.50

Price Performance

Historical Comparison
TENX
FLYE

About TENX Tenax Therapeutics Inc.

Tenax Therapeutics Inc is a phase three, development-stage pharmaceutical company focused on identifying and developing therapeutics that address cardiovascular and pulmonary diseases with high unmet medical need, with an initial therapeutic focus on pulmonary hypertension. Its drug development pipeline comprises: Levosimendan, a novel, first-in-class K-ATP activator and calcium sensitizer developed for intravenous use in hospitalized patients with acutely decompensated heart failure; and Imatinib, as a potential therapy for pulmonary arterial hypertension. The company is currently conducting clinical trials only for levosimendan as its prioritized product candidate to evaluate its potential to help patients with pulmonary hypertension.

About FLYE Fly-E Group Inc.

Fly-E Group Inc is principally engaged in designing, installing and selling smart electric motorcycles, electric bikes, electric scooters, and related accessories under the Fly E-Bike brand. It offers 27 E-motorcycle products, 37 E-bike products and 38 E-scooter products.

Share on Social Networks: